Skip to content
Email
LinkedIn
Twitter
Search for:
Home
About
Vision & Mission
People
CSR
Portfolio
Novels
Diagnostics
Tempus
BGI
Color
Order a Test Now
Special Access Programs
Dinutuximab- Beta
Neratinib
Darinaparsin
Carmustine Wafers
5-ALA
Dexrazoxane
Asparaginase Erwinia Chrysanthemi
Foscarnet
Mitotane
Electric Field Therapy
TARE
Commercially Approved Products
DC Bead
Cryoablation
PENNSAID
Lymphoseek
Biosimilars
RasCase
PegNustim
MejorAsp
TramoSayr
Niche Generics
CelstemX
Octri-Lar
Caveolin-Ptx
Say T2
Du-Kinib
Solfredoc RTU
Cladtrios
Carzo-60
Alliances
Newsroom
Press
Blogs
Careers
Contact Us
Home
>
Press
Press
admin
2024-07-03T09:32:29+00:00
Press
EMulate Therapeutics
®
Inks Distribution Agreement for India with Sayre Therapeutics
17 Oct 2019 Source: SEATTLE (PRWEB)
Sayre Therapeutics raises funds from Venture Capital firms (VCs)
04 Sep 2017 Source: Live mint
Sayre Therapeutics in agreement with GP Pharm
03 April 2017 Source: expresspharma
Sayre Therapeutics announces distribution agreement with Cancer Genetics Inc.
26 October 2016 Source: indiainfoline
Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics
JUNE 20, 2017Source: Business Wire[IST]
Nuvo Pharmaceuticals Enters into Pennsaid
®
2% License Agreement with Sayre Therapeutics. for India, Sri Lanka, Bangladesh and Nepal
NEWS PROVIDED BY Nuvo Pharmaceuticals Inc.28 Mar, 2017, 07:30 ET
Sayre Therapeutics announces DaunoXome named patient program in India
October 04, 2016, 12:44 IST | Source: ETHealthWorld
CROSSJECT enters into partnering agreement with Sayre Therapeutics to commercialize ZENEO
®
Methotrexate in India
Chenôve (France) and Bangalore (India), September 14 2015
Page load link
Go to Top